MOVE · Corvex, Inc.
One customer — 52% of revenue (the three months ended March 31, 2026)
“One customer accounted for approximately 52% of the Company’s revenue for the three months ended March 31, 2026, related to the Company’s AI cloud computing business.”
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-07 | Demsey Seth |
Director |
Other↓
Filing footnotes — Series C Preferred Stock (Direct)
The Series C Preferred Stock automatically converted into shares of common stock on July 7, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 5,484.3883 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The preferred stock is perpetual and therefore has no expiration date |
Series C Preferred Stock
|
5,484 |
| 2026-07-07 | Demsey Seth |
Director |
Other↓
Filing footnotes — Series C Preferred Stock (Indirect)
The Series C Preferred Stock automatically converted into shares of common stock on July 7, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 31.2700 shares of Series C Preferred Stock into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by Ainsworth Holdings, LLC ("Ainsworth"). The Reporting Person is the managing member of Ainsworth and has sole voting and dispositive power over the common stock held by Ainsworth. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The preferred stock is perpetual and therefore has no expiration date |
Series C Preferred Stock
(I)
|
31 |
| 2026-07-07 | Demsey Seth |
Director |
Other↑
Filing footnotes — Common Stock (Indirect)
Based on automatic conversion of 31.2700 shares of Series C Preferred Stock into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by Ainsworth Holdings, LLC ("Ainsworth"). The Reporting Person is the managing member of Ainsworth and has sole voting and dispositive power over the common stock held by Ainsworth. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
31,270 |
| 2026-07-07 | Crystal John Adler III |
Chief Executive Officer |
Other↓
Filing footnotes — Series C Preferred Stock (Direct)
The Series C Preferred Stock automatically converted into shares of common stock on July 7, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 3,345.5239 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The preferred stock is perpetual and therefore has no expiration date |
Series C Preferred Stock
|
3,345 |
| 2026-07-07 | Demsey Seth |
Director |
Other↑
Filing footnotes — Common Stock (Direct)
Based on automatic conversion of 5,484.3883 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). Includes unvested restricted stock units. |
Common Stock
|
5,484,388 |
| 2026-07-07 | FAIRBAIRN EMILY |
Director |
Other↓
Filing footnotes — Series C Preferred Stock (Indirect)
The Series C Preferred Stock automatically converted into shares of common stock on July 7, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 1,205.2825 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The preferred stock is perpetual and therefore has no expiration date The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. |
Series C Preferred Stock
(I)
|
1,205 |
| 2026-07-07 | FAIRBAIRN EMILY |
Director |
Other↑
Filing footnotes — Common Stock (Indirect)
Based on automatic conversion of 1,205.2825 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. |
Common Stock
(I)
|
1,205,282 |
| 2026-07-07 | Crystal John Adler III |
Chief Executive Officer |
Other↑
Filing footnotes — Common Stock (Direct)
Based on automatic conversion of 3,345.5239 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the "Series C Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). Includes unvested restricted stock units. |
Common Stock
|
3,345,523 |
| 2026-07-07 | Crystal John Adler III |
Chief Executive Officer |
Other↑
Filing footnotes — Common Stock (Indirect)
Based on automatic conversion of 708.1544 shares of Series C Preferred Stock into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by John Adler Crystal III Roth IRA ("Roth IRA") for the benefit of the Reporting Person. The Reporting Person has sole voting and dispositive power over the common stock held by the Roth IRA. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
708,154 |
| 2026-07-07 | Crystal John Adler III |
Chief Executive Officer |
Other↓
Filing footnotes — Series C Preferred Stock (Indirect)
The Series C Preferred Stock automatically converted into shares of common stock on July 7, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 708.1544 shares of Series C Preferred Stock into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by John Adler Crystal III Roth IRA ("Roth IRA") for the benefit of the Reporting Person. The Reporting Person has sole voting and dispositive power over the common stock held by the Roth IRA. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The preferred stock is perpetual and therefore has no expiration date |
Series C Preferred Stock
(I)
|
708 |
| 2026-07-01 | Cullinan Brian |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of time-based restricted stock units that vest in three equal annual installments from the grant date. |
Common Stock
|
50,000 |
| 2026-07-01 | FAIRBAIRN EMILY |
Director |
Award↑
Filing footnotes — Series D Preferred Stock (Indirect)
The shares of Series D Preferred Stock will convert at a conversion ratio of 1 to 1000 shares of common stock upon the delivery of a conversion notice by the Reporting Person to the Issuer. On July 1, 2026, the Reporting Person exchanged 858.5403 shares of Series C Preferred Stock for 858.5403 shares of Series D Preferred Stock on a one-for-one basis pursuant to an Exchange Agreement entered into with the Issuer. The preferred stock is perpetual and therefore has no expiration date. The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. |
Series D Preferred Stock
(I)
|
858 |
| 2026-07-01 | FAIRBAIRN EMILY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of time-based restricted stock units that vest in three equal annual installments from the grant date. As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend. |
Common Stock
|
135,800 |
| 2026-07-01 | Fleury Patrick |
Chief Financial Officer |
Award↑
Filing footnotes — Common stock (Direct)
Represents a grant of time-based restricted stock units that vest in three equal annual installments from the grant date. |
Common stock
|
100,000 |
| 2026-07-01 | Fleury Patrick |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Options (Right to Buy) (Direct)
Options will vest in three equal annual installments from the grant date. |
Stock Options (Right to Buy)
|
200,000 |
| 2026-07-01 | DONOFRIO NICHOLAS M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of time-based restricted stock units that vest in three equal annual installments from the grant date. |
Common Stock
|
50,000 |
| 2026-07-01 | FAIRBAIRN EMILY |
Director |
Other↓
Filing footnotes — Series C Preferred Stock (Indirect)
The shares of Series C Preferred Stock will convert at a conversion ratio of 1 to 1000 shares of common stock on July 7, 2026. On July 1, 2026, the Reporting Person exchanged 858.5403 shares of Series C Preferred Stock for 858.5403 shares of Series D Preferred Stock on a one-for-one basis pursuant to an Exchange Agreement entered into with the Issuer. The preferred stock is perpetual and therefore has no expiration date. The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. |
Series C Preferred Stock
(I)
|
858 |
| 2026-07-01 | Fleury Patrick |
Chief Financial Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-07-01 | DONOFRIO NICHOLAS M |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-07-01 | Moreland Christopher |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents time-based restricted stock units that vest in four equal annual installments from the grant date. |
Common Stock
|
523,211 |
| 2026-06-30 | Cullinan Brian |
Director |
Convert↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend. |
Stock Options (Right to Buy)
|
48,209 |
| 2026-06-30 | Cullinan Brian |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend. |
Common Stock
|
48,209 |
| 2026-06-29 | Moreland Christopher |
CFO |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-25 | Caballero Ruben |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
As a result of the Company's stock dividend, each share of Common Stock issued and outstanding at the close of business on March 30, 2026 was automatically converted into 1.358 shares of Common Stock and was distributed on approximately April 6, 2026. The amounts reported on this Form 4 reflect the impacts of such stock dividend. |
Common Stock
|
29,197 |
| 2026-06-25 | Caballero Ruben |
Director |
Convert↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. The number of subject shares and the exercise price of such option award has been adjusted by the stock dividend. |
Stock Options (Right to Buy)
|
29,197 |
| 2026-03-31 | FAIRBAIRN EMILY |
Director |
Other↑
Filing footnotes — Common Stock (Indirect)
Based on automatic conversion of 9.2319 shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by the Moira Partners, LLC. Emily Fairbairn is the Managing Member of Moira Partners and has voting and investment power over the securities held by Moira Partners. Ms. Fairbairn disclaims beneficial ownership of the securities held by Moira Partners, except to the extent of her pecuniary interest therein. |
Common Stock
(I)
|
9,231 |
| 2026-03-31 | FAIRBAIRN EMILY |
Director |
Other↓
Filing footnotes — Series B Preferred Stock (Direct)
The Series B Preferred Stock automatically converts into shares of common stock on March 31, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 9.2319 shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The preferred stock is perpetual and therefore has no expiration date |
Series B Preferred Stock
|
9 |
| 2026-03-31 | Crystal John Adler III |
Chief Executive Officer |
Other↑
Filing footnotes — Common Stock (Indirect)
Based on automatic conversion of 3.1677 shares of Series B Preferred Stock into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by John Adler Crystal III Roth IRA ("Roth IRA") for the benefit of the Reporting Person. The Reporting Person has sole voting and dispositive power over the common stock held by the Roth IRA. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
3,167 |
| 2026-03-31 | Demsey Seth |
Director |
Other↓
Filing footnotes — Series B Preferred Stock (Direct)
The Series B Preferred Stock automatically converts into shares of common stock on March 31, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 24.5327 shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The preferred stock is perpetual and therefore has no expiration date |
Series B Preferred Stock
|
24 |
| 2026-03-31 | Demsey Seth |
Director |
Other↓
Filing footnotes — Series B Preferred Stock (Indirect)
The Series B Preferred Stock automatically converts into shares of common stock on March 31, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 0.1399 shares of Series B Preferred Stock into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by Ainsworth Holdings, LLC ("Ainsworth"). The Reporting Person is the managing member of Ainsworth and has sole voting and dispositive power over the common stock held by Ainsworth. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The preferred stock is perpetual and therefore has no expiration date |
Series B Preferred Stock
(I)
|
0 |
| 2026-03-31 | Crystal John Adler III |
Chief Executive Officer |
Other↓
Filing footnotes — Series B Preferred Stock (Indirect)
The Series B Preferred Stock automatically converts into shares of common stock on March 31, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 3.1677 shares of Series B Preferred Stock into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by John Adler Crystal III Roth IRA ("Roth IRA") for the benefit of the Reporting Person. The Reporting Person has sole voting and dispositive power over the common stock held by the Roth IRA. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The preferred stock is perpetual and therefore has no expiration date |
Series B Preferred Stock
(I)
|
3 |
| 2026-03-31 | Demsey Seth |
Director |
Other↑
Filing footnotes — Common Stock (Direct)
Based on automatic conversion of 24.5327 shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). Includes unvested restricted stock units. |
Common Stock
|
24,532 |
| 2026-03-31 | Crystal John Adler III |
Chief Executive Officer |
Other↑
Filing footnotes — Common Stock (Direct)
Based on automatic conversion of 14.9652 shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). Includes unvested restricted stock units. |
Common Stock
|
14,965 |
| 2026-03-31 | Demsey Seth |
Director |
Other↑
Filing footnotes — Common Stock (Indirect)
Based on automatic conversion of 0.1399 shares of Series B Preferred Stock into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The securities are held by Ainsworth Holdings, LLC ("Ainsworth"). The Reporting Person is the managing member of Ainsworth and has sole voting and dispositive power over the common stock held by Ainsworth. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
Common Stock
(I)
|
139 |
| 2026-03-31 | Crystal John Adler III |
Chief Executive Officer |
Other↓
Filing footnotes — Series B Preferred Stock (Direct)
The Series B Preferred Stock automatically converts into shares of common stock on March 31, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Based on automatic conversion of 14.9652 shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the "Series B Preferred Stock") into shares of common stock at a conversion ratio of 1 to 1,000 shares of common stock (as adjusted for fractional shares paid in cash). The preferred stock is perpetual and therefore has no expiration date |
Series B Preferred Stock
|
14 |
| 2026-03-19 | FAIRBAIRN EMILY |
Director |
Award↑
Filing footnotes — Series B Preferred Stock (Direct)
The Series B Preferred Stock automatically converts into shares of the Issuer's common stock on March 31, 2026 at a conversion ratio of 1 to 1000 shares of common stock. Represents shares of preferred stock received in exchange for the Reporting Person's equity securities in Corvex, Inc. pursuant to the terms of the Amended and Restated Agreement and Plan of Merger, dated March 19, 2026, by and among the Issuer, Thor Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Issuer, and Corvex, Inc. The preferred stock is perpetual and therefore has no expiration date |
Series B Preferred Stock
|
9 |
| 2026-03-19 | FAIRBAIRN EMILY |
Director |
Award↑
Filing footnotes — Series C Preferred Stock (Direct)
The shares of Series C Preferred Stock will convert at a conversion ratio of 1 to 1000 shares of common stock upon approval of the Issuer's stockholders for such conversion pursuant to Nasdaq listing rules. Represents shares of preferred stock received in exchange for the Reporting Person's equity securities in Corvex, Inc. pursuant to the terms of the Amended and Restated Agreement and Plan of Merger, dated March 19, 2026, by and among the Issuer, Thor Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Issuer, and Corvex, Inc. The preferred stock is perpetual and therefore has no expiration date |
Series C Preferred Stock
|
2,063 |
| 2026-03-18 | FAIRBAIRN EMILY |
Director |
Award↑
Filing footnotes — Stock option (right to buy) (Direct)
This option award vests in three equal annual installments on the anniversary of the grant date. This option award will become exerciseable upon shareholder approval of such award. |
Stock option (right to buy)
|
200,000 |
| 2026-03-18 | Cogan Jeremy |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
The reported transaction involved the reporting person's receipt of a grant of restricted stock units ("RSUs") under the Company's Omnibus Incentive Plan. |
Common Stock
|
37,000 |
| 2026-03-16 | FAIRBAIRN EMILY |
Director |
Convert↑
|
Common Stock
|
55,250 |
| 2026-03-16 | FAIRBAIRN EMILY |
Director |
Convert↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. |
Stock Options (Right to Buy)
|
55,250 |
| 2026-03-13 | Wirk Shaheen |
Director |
Convert↑
|
Common Stock
|
10,000 |
| 2026-03-13 | Wirk Shaheen |
Director |
Convert↓
Filing footnotes — Stock Options (Right to Buy) (Direct)
This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option became exerciseable upon shareholder approval of the Plan Amendment on December 16, 2025. |
Stock Options (Right to Buy)
|
10,000 |
| 2026-01-27 | Cogan Jeremy |
CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.70 to $22.24 inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
5,548 |
| 2026-01-27 | Mastrototaro John |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.335 to $23.38 inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
2,407 |
| 2026-01-27 | Mastrototaro John |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.65 to $22.24 inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
5,746 |
| 2026-01-27 | Cogan Jeremy |
CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.335 to $23.38 inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
2,099 |
| 2026-01-27 | Mastrototaro John |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $21.575 inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
14,960 |
| 2026-01-27 | Cogan Jeremy |
CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.50 to $20.50, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
4,622 |
| 2026-01-27 | Mastrototaro John |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents shares sold to pay withholding taxes and exercise prices due in connection with the exercise of stock option awards granted to the reporting person in lieu of cash salary during 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.59 to $20.59, inclusive. The reporting person undertakes to provide to Movano Inc., any security holder of Movano Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Common Stock
|
5,444 |